CLX CLOROX CO DEL revenue, earnings and financials

For the quarter ended March 31, 2026, CLOROX CO DEL reported revenue of $1.67B (up 0.1% from a year earlier), net income of $187M and diluted EPS of $1.54; over the last four quarters revenue was $6.76B and net income $770M; for the fiscal year ended June 2025 revenue was $7.10B, up 0.2% on the year before.

CLX annual revenue and earnings

• Fiscal year ended Jun 2025: revenue $7.10B, gross profit $3.21B, operating income n/a, net income $824M (margin 11.6%), EPS $6.52
• Fiscal year ended Jun 2024: revenue $7.09B, gross profit $3.05B, operating income n/a, net income $292M (margin 4.1%), EPS $2.25
• Fiscal year ended Jun 2023: revenue $7.39B, gross profit $2.91B, operating income n/a, net income $161M (margin 2.2%), EPS $1.20
• Fiscal year ended Jun 2022: revenue $7.11B, gross profit $2.55B, operating income n/a, net income $471M (margin 6.6%), EPS $3.73
• Fiscal year ended Jun 2021: revenue $7.34B, gross profit $3.20B, operating income n/a, net income $710M (margin 9.7%), EPS $5.58

CLX quarterly revenue and earnings

• Quarter ended Mar 31, 2026: revenue $1.67B (up 0.1% year over year), net income $187M, EPS $1.54
• Quarter ended Dec 31, 2025: revenue $1.67B (down 0.8% year over year), net income $157M, EPS $1.29
• Quarter ended Sep 30, 2025: revenue $1.43B (down 18.9% year over year), net income $80.0M, EPS $0.65
• Quarter ended Jun 30, 2025 (from the annual report): revenue $1.99B (up 4.5% year over year), net income $346M, EPS $2.68
• Quarter ended Mar 31, 2025: revenue $1.67B (down 8.0% year over year), net income $186M, EPS $1.50
• Quarter ended Dec 31, 2024: revenue $1.69B (down 15.3% year over year), net income $193M, EPS $1.54
• Quarter ended Sep 30, 2024: revenue $1.76B (up 27.1% year over year), net income $99.0M, EPS $0.80
• Quarter ended Jun 30, 2024 (from the annual report): revenue $1.90B (down 5.7% year over year), net income $228M, EPS $1.74
• Quarter ended Mar 31, 2024: revenue $1.81B (down 5.3% year over year), net income −$51.0M, EPS −$0.41
• Quarter ended Dec 31, 2023: revenue $1.99B (up 16.0% year over year), net income $93.0M, EPS $0.75
• Quarter ended Sep 30, 2023: revenue $1.39B (down 20.3% year over year), net income $22.0M, EPS $0.17
• Quarter ended Jun 30, 2023 (from the annual report): revenue $2.02B (up 12.1% year over year), net income $188M, EPS $1.43
• Quarter ended Mar 31, 2023: revenue $1.92B (up 5.9% year over year), net income −$211M, EPS −$1.71
• Quarter ended Dec 31, 2022: revenue $1.72B (up 1.4% year over year), net income $99.0M, EPS $0.80
• Quarter ended Sep 30, 2022: revenue $1.74B (down 3.7% year over year), net income $85.0M, EPS $0.68
• Quarter ended Jun 30, 2022 (from the annual report): revenue $1.80B (down 0.1% year over year), net income $110M, EPS $0.82
• Quarter ended Mar 31, 2022: revenue $1.81B (up 1.6% year over year), net income $150M, EPS $1.21
• Quarter ended Dec 31, 2021: revenue $1.69B, net income $69.0M, EPS $0.56
• Quarter ended Sep 30, 2021: revenue $1.81B, net income $142M, EPS $1.14
• Quarter ended Jun 30, 2021: revenue $1.80B, net income $97.0M, EPS $0.78

CLX cash flow, buybacks and dividends

• Fiscal year ended Jun 2025: operating cash flow $981M, share buybacks $332M, dividends $4.88 per share
• Fiscal year ended Jun 2024: operating cash flow $695M, share buybacks $0, dividends $4.80 per share
• Fiscal year ended Jun 2023: operating cash flow $1.16B, share buybacks $0, dividends $4.72 per share
• Fiscal year ended Jun 2022: operating cash flow $786M, share buybacks $25.0M, dividends $3.48 per share
• Fiscal year ended Jun 2021: operating cash flow $1.28B, share buybacks $905M, dividends $4.49 per share

CLX balance sheet

• Mar 31, 2026: cash $1.19B, total assets $6.44B, total liabilities $6.34B, shareholders' equity −$67.0M, long-term debt $2.49B
• Dec 31, 2025: cash $227M, total assets $5.61B, total liabilities $5.58B, shareholders' equity −$125M, long-term debt $2.49B
• Sep 30, 2025: cash $166M, total assets $5.53B, total liabilities $5.39B, shareholders' equity −$22.0M, long-term debt $2.49B
• Jun 30, 2025: cash $167M, total assets $5.56B, total liabilities $5.08B, shareholders' equity $321M, long-term debt $2.48B
• Mar 31, 2025: cash $226M, total assets $5.51B, total liabilities $5.32B, shareholders' equity $27.0M, long-term debt $2.48B
• Dec 31, 2024: cash $290M, total assets $5.58B, total liabilities $5.46B, shareholders' equity −$41.0M, long-term debt $2.48B
• Sep 30, 2024: cash $278M, total assets $5.50B, total liabilities $5.27B, shareholders' equity $60.0M, long-term debt $2.48B
• Jun 30, 2024: cash $202M, total assets $5.75B, total liabilities $5.26B, shareholders' equity $328M, long-term debt $2.48B

What is CLX's revenue?

CLOROX CO DEL reported $6.76B of revenue over its last four quarters, through March 31, 2026.

Is CLX profitable?

Yes. CLOROX CO DEL earned $770M over the last four quarters.

What is CLX's EPS?

Diluted earnings per share over the last four quarters were $6.16; $1.54 in the latest quarter.

Does CLX pay a dividend?

CLOROX CO DEL paid $4.88 per share in dividends in the fiscal year ended June 2025.

CLX ownership and insider trades · All stocks